All Professionals
Overview
Lauren Y. Zhang is an associate in the Securities and Capital Markets practice of Paul Hastings and is based in the firm’s New York office. Her practice includes representation of clients across the life sciences and technology industries, which include global investment banks as well as public and private companies. Ms. Zhang advises clients in a variety of capital markets transactions including IPOs, follow-on offerings, and private placements of securities, as well as venture financings, securities law compliance, and corporate governance.
Representations
- BofA Securities and the other underwriters in the $110 million Initial Public Offering by Fractyl Health, Inc.
- Goldman Sachs & Co. LLC in follow-on offering by Taysha Gene Therapies
- Goldman Sachs & Co. LLC and other underwriters in the $150 million follow-on offering by Syndax Pharmaceuticals, Inc.
- Goldman Sachs & Co. LLC and the other initial purchasers in the $230 million convertible notes offering by Cutera, Inc.
- J.P. Morgan Securities and other underwriters in the $75 million follow-on offering by Precigen, Inc.
- Leerink and other underwriters in the $50 million follow-on offering by scPharmaceuticals Inc.
- Piper Sandler and Raymond James in the $85 million follow-on offering by CymaBay Therapeutics, Inc.
- HOOKIPA Pharma Inc., in its follow-on offerings aggregating over $120 million in proceeds
- Cowen as sales agent in the ATM facility for DermTech, Inc.
- Jefferies as sales agent in multiple ATM facilities, including ImmunoPrecise Antibodies Ltd., and Sensei Biotherapeutics, Inc.
Matters may have been completed before joining Paul Hastings.
news
- Paul Hastings Advised J.P. Morgan in Connection with Leap Therapeutics’ PIPE Financing - April 11th, 2024
- Paul Hastings Advised BofA Securities in Connection with Century Therapeutics’ PIPE Financing - April 11th, 2024
- Paul Hastings Advised Leerink Partners and Stifel in connection with Evolus Inc.’s Underwritten Offering - March 12th, 2024